New SPACs are getting announced every day, including in biotech: so much so that serial entrepreneur Mike Gilman tweeted that “it’s raining SPACs” – a sentiment that captures the frenzied downpour of activity.
Foresite Capital’s SPAC FS Development prices upsized $105 million IPO at $10
Foresite Capital’s SPAC FS Development prices upsized $105 million IPO at $10 FS Development, a blank check company formed by Foresite Capital targeting a healthcare…